Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 41, 2011 - Issue 6
238
Views
9
CrossRef citations to date
0
Altmetric
Pharmacogenetics

Effects of CYP2C19 polymorphism on the pharmacokinetics of lansoprazole and its main metabolites in healthy Chinese subjects

, , , &
Pages 511-517 | Received 15 Nov 2010, Accepted 28 Jan 2011, Published online: 27 Apr 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Dan Zhang, Man Yang, Man Liu, Yanan Zhang, Xiaolin Wang, Xue Xiao & Huichen Liu. (2012) Pharmacokinetics of lansoprazole and its main metabolites after single intravenous doses in healthy Chinese subjects. Xenobiotica 42:11, pages 1156-1162.
Read now

Articles from other publishers (8)

Caroline Sychterz, Iain Gardner, Manting Chiang, Ramakrishna Rachumallu, Sibylle Neuhoff, Vidya Perera, Samira Merali, Brian J. Schmidt & Lu Gaohua. (2022) Performance Verification of CYP2C19 Enzyme Abundance Polymorphism Settings within the Simcyp Simulator v21. Metabolites 12:10, pages 1001.
Crossref
He-Jian Zhang, Xue-Hui Zhang, Jie Liu, Lu-Ning Sun, Yi-Wen Shen, Chen Zhou, Hong-Wen Zhang, Li-Jun Xie, Juan Chen, Yun Liu & Yong-Qing Wang. (2020) Effects of genetic polymorphisms on the pharmacokinetics and pharmacodynamics of proton pump inhibitors. Pharmacological Research 152, pages 104606.
Crossref
Katarína Kostolanská, Ondřej Peš, Ondřej Zendulka, Jan Máchal & Jan Juřica. (2019) Determination of lansoprazole, 5-hydroxylansoprazole, and lansoprazole sulfone in human plasma for CYP2C19 and CYP3A4 phenotyping. Chemical Papers 73:12, pages 2955-2963.
Crossref
Li Zhou, Pradeep Sharma, Karen Rowland Yeo, Mitsuo Higashimori, Hongmei Xu, Nidal Al-Huniti & Diansong Zhou. (2019) Assessing pharmacokinetic differences in Caucasian and East Asian (Japanese, Chinese and Korean) populations driven by CYP2C19 polymorphism using physiologically-based pharmacokinetic modelling. European Journal of Pharmaceutical Sciences 139, pages 105061.
Crossref
Sijie Lu, R. A. Nand, J. S. Yang, Gang Chen & A. S. Gross. (2017) Pharmacokinetics of CYP2C9, CYP2C19, and CYP2D6 substrates in healthy Chinese and European subjects. European Journal of Clinical Pharmacology 74:3, pages 285-296.
Crossref
John J Lima & James P Franciosi. (2014) Pharmacogenomic testing: the case for CYP2C19 proton pump inhibitor gene–drug pairs . Pharmacogenomics 15:11, pages 1405-1416.
Crossref
Chang-Yin Li, Jun Zhang, Ji-Hong Chu, Mei-Juan Xu, Wen-Zheng Ju, Fang Liu & Jian-Dong Zou. (2013) A correlative study of polymorphisms of CYP2C19 and MDR1 C3435T with the pharmacokinetic profiles of lansoprazole and its main metabolites following single oral administration in healthy adult Chinese subjects. European Journal of Drug Metabolism and Pharmacokinetics 39:2, pages 121-128.
Crossref
Dan Zhang, Yanan Zhang, Man Liu, Xiaolin Wang, Man Yang, Jing Han & Huichen Liu. (2012) Pharmacokinetics of lansoprazole and its main metabolites after single and multiple intravenous doses in healthy Chinese subjects. European Journal of Drug Metabolism and Pharmacokinetics 38:3, pages 209-215.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.